Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
ImmunoCellular Announces Receipt of Notice of Noncompliance with The NYSE American Continued Listing Standards PR Newswire LOS ANGELES, Oct. 17, 2018 LOS ANGELES, Oct. 17, 2018 /PRNewswire/...
ImmunoCellular Therapeutics Announces Delisting and Deregistration of Common Stock and Listed Common Stock Warrants Management Team to Transition to Consulting Roles in Effort to Streamline...
ImmunoCellular Therapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results -Ongoing Exploration of Strategic Opportunities- -Continued Progress in Stem-to-T-Cell...
ImmunoCellular Therapeutics Announces Agreement on Terms of Settlement of Federal Class Action Shareholder Lawsuit Settlement Will Be Paid By Company's Insurance Carrier PR Newswire LOS ANGELES...
ImmunoCellular Therapeutics Announces First Quarter 2018 Financial Results -Continued Progress in Stem-to-T-Cell Program- -Ongoing Exploration of Strategic Opportunities- PR Newswire LOS ANGELES...
ImmunoCellular Therapeutics Announces Achievement of Next Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program PR Newswire LOS ANGELES, April 12, 2018 LOS ANGELES, April 12, 2018...
ImmunoCellular Therapeutics Receives Audit Opinion with Going Concern Explanation PR Newswire LOS ANGELES, March 26, 2018 LOS ANGELES, March 26, 2018 /PRNewswire/ -- ImmunoCellular Therapeutics...
ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results -Continued Progress in Stem-to-T-Cell Program- -Strengthened Financial Condition- -Conference Call Today...
ImmunoCellular Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018 PR Newswire LOS ANGELES, March 7, 2018 LOS ANGELES, March 7, 2018 /PRNewswire/...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0039 | -2.24266820012 | 0.1739 | 0.1739 | 0.1051 | 680 | 0.1634411 | CS |
| 4 | 0.0799 | 88.679245283 | 0.0901 | 0.205 | 0.0901 | 2048 | 0.16446496 | CS |
| 12 | 0.086 | 102.380952381 | 0.084 | 0.205 | 0.079 | 1807 | 0.12488149 | CS |
| 26 | 0.07 | 70 | 0.1 | 0.205 | 0.072 | 2360 | 0.14304942 | CS |
| 52 | -0.16 | -48.4848484848 | 0.33 | 0.3999 | 0.0182 | 2859 | 0.19113567 | CS |
| 156 | -0.43 | -71.6666666667 | 0.6 | 0.94 | 0.0182 | 5282 | 0.37410056 | CS |
| 260 | 0.1321 | 348.548812665 | 0.0379 | 0.98 | 0.0161 | 19647 | 0.17468406 | CS |
| Symbole | Prix | Vol. |
|---|---|---|
| AITXArtificial Intelligence Technology Solutions Inc (PK) | US$ 0,00275 (0,00%) | 51,06M |
| GTEHGenTech Holdings Inc (CE) | US$ 0,000001 (0,00%) | 48,25M |
| HMBLHUMBL Inc (PK) | US$ 0,0002 (-33,33%) | 42,65M |
| CBGLCannabis Global Inc (PK) | US$ 0,00015 (50,00%) | 41,81M |
| GTVHGolden Triangle Ventures Inc (PK) | US$ 0,0008 (33,33%) | 41,61M |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
